Rockefeller Capital Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$525K Sell
5,509
-436
-7% -$46.5K ﹤0.01% 2109
2026
Q2
$660K Buy
5,945
+1,101
+23% +$100K ﹤0.01% 1937
2026
Q1
$421K Sell
4,844
-6,927
-59% -$674K ﹤0.01% 2077
2025
Q4
$1.26M Buy
11,771
+2,903
+33% +$308K ﹤0.01% 1459
2025
Q3
$896K Buy
+8,868
New +$823K ﹤0.01% 1468
2020
Q1
– Sell
-249
Closed -$6K – 2467
2019
Q4
$6K Hold
249
– – ﹤0.01% 1750
2019
Q3
$5K Hold
249
– – ﹤0.01% 1638
2019
Q2
$5K Hold
249
– – ﹤0.01% 1434
2019
Q1
$7K Buy
+249
New +$7.16K ﹤0.01% 1572

Other funds holding RYTM

Rockefeller Capital Management's RYTM Position: Q3 2026 in Review

Rockefeller Capital Management reduced its Rhythm Pharmaceuticals (RYTM) stake by 7.3% in Q3 2026, selling an estimated $46.5K and leaving 5,509 shares worth $525K. The position accounts for ﹤0.01% of the portfolio, ranked #2109.

Rockefeller Capital Management first reported a position in RYTM in Q1 2019 and has held it in 9 quarters since. The position peaked at $1.26M in Q4 2025. 333 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.

  • Rockefeller Capital Management held 5,509 shares of Rhythm Pharmaceuticals worth $525K as of Q3 2026.
  • Rockefeller Capital Management sold 436 Rhythm Pharmaceuticals shares in Q3 2026, an estimated $46.5K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #2109 holding.
  • Rockefeller Capital Management first reported a position in Rhythm Pharmaceuticals in Q1 2019 and has held it in 9 quarters since.
  • Rockefeller Capital Management's Rhythm Pharmaceuticals position peaked at $1.26M in Q4 2025.
  • 333 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.

Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.